Showing results (81-90 of 163) with videos related to

Sort By:
Pageof 17
Haematologica|December 1, 2020
Dasatinib response in acute myeloid leukemia is correlated with FLT3/ITD, PTPN11 mutations and a unique gene expression signatureSigal Tavor, Tali Shalit, Noa Chapal Ilani, et al.
Blood|May 26, 2005
High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: correlation with clonal cytogenetic evolution but not response to therapyStephanie G Willis, Thoralf Lange, Shadmehr Demehri, et al.
Blood|August 23, 2003
In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl-positive cell linesPaul La Rosée, Kara Johnson, Amie S Corbin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Antileukemic activity of lysophosphatidic acid acyltransferase-beta inhibitor CT32228 in chronic myelogenous leukemia sensitive and resistant to imatinibPaul La Rosée, Taiping Jia, Shadmer Demehri, et al.
Genome Research|January 9, 2024
A Bayesian framework to study tumor subclone-specific expression by combining bulk DNA and single-cell RNA sequencing dataYi Qiao, Xiaomeng Huang, Philip J Moos, et al.
Leukemia Research|February 9, 2006
Phosphoproteomic analysis of AML cell lines identifies leukemic oncogenesDenise K Walters, Valerie L Goss, Eric P Stoffregen, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 15, 2019
Drug-free macromolecular therapeutics induce apoptosis in cells isolated from patients with B cell malignancies with enhanced apoptosis induction by pretreatment with gemcitabineJiawei Wang, Lian Li, Jiyuan Yang, et al.
Blood|June 19, 2008
Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative diseaseAnupriya Agarwal, Thomas G P Bumm, Amie S Corbin, et al.
Leukemia|January 26, 2007
Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinibD W Sherbenou, M J Wong, A Humayun, et al.
JMIR Research Protocols|May 22, 2023
Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping ReviewJonathan E Constance, Mary M McFarland, Tallie Casucci, et al.
Pageof 17